Claudio C. De Lima
211 Professor Antonio Prudente Street
Sao Paulo, SP 01509900, Brazil
Sao Paulo, SP 01509900, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Clinicogenomic and treatment outcomes in RET fusion-positive NSCLC: A multicenter study in Latin American Hispanic patients.
Journal: Cancer treatment and research communications
Published: January 24, 2025
Rhabdomyosarcomatous Transformation as a Mechanism of Resistance to Osimertinib and Savolitinib in EGFR-Mutant Lung Adenocarcinoma With METamp After Osimertinib First-Line Treatment.
Journal: JCO precision oncology
Published: October 06, 2022
Induction of pyroptotic cell death as a potential tool for cancer treatment.
Journal: Journal of inflammation (London, England)
Published: July 25, 2022
HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer.
Journal: Breast cancer research and treatment
Published: April 17, 2021
BuCyE can safely replace BEAM as a conditioning regimen for autologous stem cell transplantation in the treatment of refractory and relapsed lymphomas.
Journal: Leukemia research
Published: March 29, 2021
NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer.
Journal: Journal of biomedical science
Published: January 05, 2021
Anti-PD1 versus anti-PD-L1 immunotherapy in first-line therapy for advanced non-small cell lung cancer: A systematic review and meta-analysis.
Journal: Thoracic cancer
Published: November 22, 2020
Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma.
Journal: BMC cancer
Published: May 18, 2020
Single-nucleotide variants in TGFB1, TGFBR2, IL17A, and IL17F immune response genes contribute to follicular lymphoma susceptibility and aggressiveness.
Journal: Blood cancer journal
Published: May 05, 2020
An integrative microenvironment approach for follicular lymphoma: roles of inflammatory cell subsets and immune-response polymorphisms on disease clinical course.
Journal: Oncotarget
Published: March 11, 2020
Last Updated: 09/26/2026